Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Analog Devices Appoints Andrea F. Wainer to its Board of Directors

ADI

WILMINGTON, Mass., Jan. 22, 2025 /PRNewswire/ -- Analog Devices, Inc. (NASDAQ: ADI) today announced the appointment of Andrea F. Wainer, a seasoned healthcare executive, to its Board of Directors as an independent director. She will also serve as a member of the Board's Nominating and Corporate Governance Committee.

Analog Devices appoints Andrea F. Wainer to its Board of Directors

"We are delighted to welcome Andrea to the ADI Board, as her deep experience and leadership in the healthcare sector will provide ADI with an important source of wisdom and knowledge as we navigate the rich opportunity landscape ahead of us," said Vincent Roche, ADI's CEO and Chair.

Wainer is a highly versatile, results-oriented leader with expertise leading innovative businesses at Abbott Laboratories (Abbott), Pfizer and Astellas Pharma. Since 2019, she has served as Executive Vice President, Rapid and Molecular Diagnostics at Abbott. In this role, she leads three businesses – one focused on molecular diagnostics and the analysis of DNA and RNA at the molecular level, the second a provider of rapid point-of-care diagnostics, and the third delivers a leading hand-held point-of-care device.

Previous roles held include President, Abbott Molecular Diagnostics; President, Abbott Animal Health; and Divisional Vice President/General Manager, Abbott Renal Care.

Wainer also serves as a member of the Board of Trustees of the Goodman Theatre.

She earned a Bachelor's Degree in Accounting from the John M. Olin School of Business, Washington University and a Master's Degree in Business Administration from the Kellogg School of Management, Northwestern University.

About Analog Devices, Inc.
Analog Devices, Inc. (NASDAQ: ADI) is a global semiconductor leader that bridges the physical and digital worlds to enable breakthroughs at the Intelligent Edge. ADI combines analog, digital, and software technologies into solutions that help drive advancements in digitized factories, mobility, and digital healthcare, combat climate change, and reliably connect humans and the world. With revenue of more than $9 billion in FY24 and approximately 24,000 people globally, ADI ensures today's innovators stay Ahead of What's Possible. Learn more at www.analog.com and on LinkedIn and Twitter (X).

All trademarks and registered trademarks are the property of their respective owners.

CONTACT:
Ferda Millan
Global PR and External Communications
Analog Devices
CorpComm@analog.com
(408) 373-1854

Michael Lucarelli
Vice President, Investor Relations and FP&A
Analog Devices
Investor.Relations@analog.com
(781) 461-3282

Analog Devices, Inc. (PRNewsfoto/Analog Devices, Inc.)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/analog-devices-appoints-andrea-f-wainer-to-its-board-of-directors-302356855.html

SOURCE Analog Devices, Inc.